Prevention of abnormal scarring in woundhealing
S100 proteins (i.e. Psoriasin, Koebnerisin) for the prevention
of abnormal scarring by reduction of excessive collagen and extracellular matrix production early after wounding.
Further Information: PDF
Bayerische Patentallianz GmbH
Phone: +49 89 5480177-0
Contact
Peer Biskup
Media Contact
All latest news from the category: Technology Offerings
Newest articles
Neurons: How RNA granules grow and shrink
LMU scientists have shown that small aggregates function as temporary RNA repositories, which are regulated by neural activity. Cells constantly have to adapt the level of activity of certain genes…
Custom ‘headphones’ boost atomic radio reception 100-fold
Researchers at the National Institute of Standards and Technology (NIST) have boosted the sensitivity of their atomic radio receiver a hundredfold by enclosing the small glass cylinder of cesium atoms…
New tech aims to drive down costs of hydrogen fuel
Researchers from North Carolina State University have developed a new technique for extracting hydrogen gas from liquid carriers which is faster, less expensive and more energy efficient than previous approaches….
